Steven Cohen Wave Life Sciences Ltd. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 28,096 shares of WVE stock, worth $384,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,096
Previous 115,478
75.67%
Holding current value
$384,072
Previous $576,000
60.07%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Ra Capital Management, L.P. Boston, MA18.2MShares$249 Million2.08% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$137 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$133 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$92.1 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$84.3 Million48.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.19B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...